Literature DB >> 16049336

Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.

Pietro Fratta1, W King Engel, Janis McFerrin, Kelvin J A Davies, Sharon W Lin, Valerie Askanas.   

Abstract

The 26S proteasome system is involved in eliminating various proteins, including ubiquitinated misfolded/unfolded proteins, and its inhibition results in cellular accumulation of protein aggregates. Intramuscle-fiber ubiquitinated multiprotein-aggregates are characteristic of sporadic inclusion-body myositis (s-IBM) muscle fibers. Two major types of aggregates exist, containing either amyloid-beta (Abeta) or phosphorylated tau (p-tau). We have now asked whether abnormalities of the 26S proteasome contribute to s-IBM pathogenesis and whether the multiprotein aggregates have features of aggresomes. Using cultured human muscle fibers we also studied the effect of amyloid-beta precursor protein (AbetaPP) overexpression on proteasome function and the influence of proteasome inhibition on aggresome formation. We report that in s-IBM muscle biopsies 26S proteasome subunits were immunodetected in the gamma-tubulin-associated aggresomes, which also contained Abeta, p-tau, ubiquitin, and HSP70. In addition, a) expression of proteasome subunits was greatly increased, b) the 20Salpha proteasome subunit co-immunoprecipitated with AbetaPP/Abeta, and c) the three major proteasomal proteolytic activities were reduced. In cultured muscle fibers, AbetaPP-overexpressing fibers displayed diminished proteasomal proteolytic activities, and addition of proteasome inhibitor strikingly increased aggresome formation. Accordingly, proteasome dysfunction in s-IBM muscle fibers may play a role in accumulation of misfolded, potentially cytotoxic proteins and may be induced by increased intracellular AbetaPP/Abeta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049336      PMCID: PMC1603556          DOI: 10.1016/s0002-9440(10)62994-x

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  The molecular and cellular pathology of inflammatory muscle diseases.

Authors:  M C Dalakas
Journal:  Curr Opin Pharmacol       Date:  2001-06       Impact factor: 5.547

2.  ADDLs & protofibrils--the missing links?

Authors:  William L Klein
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

3.  Medicine: danger--misfolding proteins.

Authors:  R John Ellis; Teresa J T Pinheiro
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 4.  Hassles with taking out the garbage: aggravating aggresomes.

Authors:  Rafael Garcia-Mata; Ya-Sheng Gao; Elizabeth Sztul
Journal:  Traffic       Date:  2002-06       Impact factor: 6.215

Review 5.  Protein degradation and the generation of MHC class I-presented peptides.

Authors:  Kenneth L Rock; Ian A York; Tomo Saric; Alfred L Goldberg
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

6.  Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis.

Authors:  V Askanas; R B Alvarez; M Mirabella; W K Engel
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

7.  Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.

Authors:  M Demasi; R Shringarpure; K J Davies
Journal:  Arch Biochem Biophys       Date:  2001-05-15       Impact factor: 4.013

8.  Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions.

Authors:  Thorsten Schmidt; Katrin S Lindenberg; Antje Krebs; Ludger Schöls; Franco Laccone; Jochen Herms; Martin Rechsteiner; Olaf Riess; G Bernhard Landwehrmeyer
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

9.  Parkin accumulation in aggresomes due to proteasome impairment.

Authors:  Eunsung Junn; Sang Seop Lee; Unsun T Suhr; M Maral Mouradian
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

10.  Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.

Authors:  Kristina Lindsten; Femke M S de Vrij; Lisette G G C Verhoef; David F Fischer; Fred W van Leeuwen; Elly M Hol; Maria G Masucci; Nico P Dantuma
Journal:  J Cell Biol       Date:  2002-04-29       Impact factor: 10.539

View more
  35 in total

1.  Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice.

Authors:  Masashi Kitazawa; Kim N Green; Antonella Caccamo; Frank M LaFerla
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

3.  In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis.

Authors:  Chiara Terracciano; Anna Nogalska; W King Engel; Valerie Askanas
Journal:  J Neurochem       Date:  2009-10-29       Impact factor: 5.372

4.  Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.

Authors:  Anna Nogalska; Carla D'Agostino; W King Engel; Mafalda Cacciottolo; Shinichi Asada; Kazutoshi Mori; Valerie Askanas
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

Review 5.  Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Authors:  Elie Naddaf; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 6.  Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease.

Authors:  Stefanie Grimm; Annika Hoehn; Kelvin J Davies; Tilman Grune
Journal:  Free Radic Res       Date:  2010-09-06

7.  AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis.

Authors:  Slawomir Wojcik; W King Engel; Janis McFerrin; Orlando Paciello; Valerie Askanas
Journal:  Neuromuscul Disord       Date:  2006-10-23       Impact factor: 4.296

8.  Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.

Authors:  Sergei I Bannykh; William E Balch; Jeffery W Kelly; Lesley J Page; G Diane Shelton
Journal:  Ultrastruct Pathol       Date:  2013-10       Impact factor: 1.094

9.  Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis.

Authors:  Jason King; Richard A LeCouteur; Monica Aleman; D Colette Williams; Peter F Moore; Ling T Guo; Andrew P Mizisin; G Diane Shelton
Journal:  Acta Neuropathol       Date:  2009-08-29       Impact factor: 17.088

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.